NCI Center for Cancer Research shared on their LinkedIn:

“NEW FINDINGS: A recent CCR advance showed an important role for hepatocyte-specific CEBPA, a ligand-independent transcriptional factor, in liver fibrosis progression (the main determinant of liver disease outcomes).

Dr. Frank J. Gonzalez, a senior investigator in our Cancer Innovation Laboratory, focuses on investigating the mechanisms of chemical carcinogenesis for colon, liver, mammary, and other cancers. His work includes the study of signal transduction pathways involving nuclear receptors and their role in cancer initiation and progression.

Video credit: iStock.”

Proceed to the video.
Source: NCI Center for Cancer Research/LinkedIn

About OncoDaily

OncoDaily was founded in 2023. It is a US-based oncology media platform, which features the latest news, insights, and patient stories from the world of oncology. Within a short period of time it became one of the leading oncology media platforms globally.

OncoDaily gathers content from various sources, including social media posts from renowned oncologists from all over the world, news from oncology societies and cancer centers, patient and survivor stories, and career-related information for professionals.

The mission of OncoDaily is to empower patients, survivors, and professionals with the knowledge and inspiration they need to fight cancer. The motto of OncoDaily is “Cancer doesn’t take a day off – neither do we”.